Oxidative stress and free radical production have been implicated in Alzheimer"s disease, where low levels of the antioxidant vitamin C (ascorbate) have been shown to be associated with the disease. In this study, neuroblastoma SH-SY5Y cells were treated with hydrogen peroxide in the presence of ascorbate in order to elucidate the mechanism(s) of protection against oxidative stress afforded by ascorbate. Protein oxidation, glutathione levels, cell viability and the effects on the proteome and its oxidized counterpart were monitored. SH-SY5Y cells treated with ascorbate prior to co-incubation with peroxide showed increased viability in comparison to cells treated with peroxide alone. This dual treatment also caused an increase in protein carbonyl content and a decrease in glutathione levels within the cells. Proteins, extracted from
Abstract:
Oxidative stress and free radical production have been implicated in Alzheimer"s disease, where low levels of the antioxidant vitamin C (ascorbate) have been shown to be associated with the disease. In this study, neuroblastoma SH-SY5Y cells were treated with hydrogen peroxide in the presence of ascorbate in order to elucidate the mechanism(s) of protection against oxidative stress afforded by ascorbate. Protein oxidation, glutathione levels, cell viability and the effects on the proteome and its oxidized counterpart were monitored. SH-SY5Y cells treated with ascorbate prior to co-incubation with peroxide showed increased viability in comparison to cells treated with peroxide alone. This dual treatment also caused an increase in protein carbonyl content and a decrease in glutathione levels within the cells. Proteins, extracted from SH-SY5Y cells that were treated with either ascorbate or peroxide alone or with ascorbate prior to peroxide, were separated by 2DE and analysed for oxidation. Coincubation for 24 hours decreased the number of oxidised proteins (e.g. Acyl CoA oxidase 3) and induced brain derived neurotrophic factor (BDNF) expression.
Enhanced expression of BDNF may contribute towards the protective effects of ascorbate against oxidative stress in neuronal cells.
Introduction:
Oxidative damage to proteins, lipids and DNA has been observed in many chronic inflammatory and degenerative diseases [1, 2] . These findings implicate oxidative stress in the disease processes, where oxidative stress arises from an imbalance between the rate of oxygen free radical generation, and their removal by low molecular weight scavengers and antioxidant enzymes [3] . The sources of oxygen radicals are diverse in pathophysiology, where they can arise from both endogenous and exogenous processes [4] . Three mechanisms have been proposed to account for elevated oxidative stress in neurodegenerative disease; the mitochondrial hypothesis where defects in the respiratory chain leads to electron loss and oxygen radical formation [5] , the response to injury hypothesis where a brain inflammatory response may explain neuronal damage [6] and the generation of peroxides from beta amyloid fragments [7, 8] .
The brain is particularly vulnerable to oxygen radical damage, through the prevalence of oxidizable polyunsaturated fatty acids in membranes, the presence of redox active metal ions and the high metabolic requirement for oxygen [9] . Normally, neuronal cells accumulate high levels of the antioxidant ascorbic acid, and synthesize greater amounts of glutathione than other cells [10] . Indeed, glutathione and ascorbate are reciprocally linked, where glutathione is important in regenerating ascorbate from its oxidised form [4] . However, epidemiological evidence in elderly subjects has shown lower plasma levels of antioxidants such as ascorbate [11] , and an inverse relationship exists between ascorbate levels and Alzheimer disease incidence [12, 13] .
Furthermore, in a clinical trial, the antioxidant efficacy of vitamin E was augmented by co-supplementation with ascorbate [14] .
In vitro studies have confirmed the importance of ascorbate as a protective molecule against oxidative stress induced neurotoxicity. Studies by McGregor et al. [15] have demonstrated that kainiate induced excitoxicity in the hippocampus can be ameliorated in the rat by dosing with vitamin C. A high concentration of ascorbate (1.5mM) prevented malondialdehyde formation in rat brain microsomes [16] . It has been shown that large amounts of ascorbate added to brain slices prevent subsequent oedema formation [17] . Li et al. [18] have also suggested that intracellular ascorbate is an effective antioxidant in neuronal cells (SH-SY5Y), and these findings support a role for ascorbate in protecting neurones from oxidant damage associated with various neurodegenerative diseases. Recent studies investigating the mechanisms of cytoprotection afforded by "antioxidants" such as ascorbate have suggested that their effects may not only lie in their capacity to reduce oxygen radicals, but also in their capacity to elicit expression of other cytoprotective molecules [19, 20] . Therefore, we have investigated the hypothesis that ascorbate protects against oxidative stress by preventing protein oxidation and inducing cellular protection mechanisms.
In this work, we have examined the protective effect of vitamin C against loss of glutathione and induction of protein carbonyls by hydrogen peroxide in neuroblastoma cells, and its capacity to elicit protection through the neuronal proteome using 2-dimensional gel electrophoresis.
Methods:
Cell culture:
Neuroblastoma cells (SH-SY5Y) were cultured using RPMI 1640 with Glutamax I (Gibco) supplemented with fetal bovine sera (15%, Gibco), non-essential amino acid solution (1%, Sigma) and penicillin (0.5U/ml, Gibco) and streptomycin (0.5mg/ml, Gibco). Cells were maintained in 75cm 2 flasks until confluent.
A 4-hour adaptive phase was allowed prior to start of treatments to allow for normalization of transient redox flux and loss of glutathione (GSH) that is associated with passage. SH-SY5Y cells were subject to 4 paradigms: 1, the true control, which had no oxidative stress or antioxidant added; 2, cells were treated with ascorbate (50-100) at 4h after seeding; 3, cells were treated with hydrogen peroxide (50-500M) at 24h after seeding; and 4, cells were treated with ascorbate (100M) 4h after seeding and then with hydrogen peroxide (100M) at 24h after seeding. All four paradigms were incubated for 48h.
Cell viability:
Triplicate samples of SH-SY5Y cells (2 x 10 5 per well) were seeded in 96-well plates and subjected to the oxidative stress/ antioxidant conditions described. Cell viability was measured as described by Hansen et al. [21] . Briefly, two hours prior to the completion of the experiment 3(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium (MTT solution;25l, 5mg/ml) was added to the wells. The cells were then incubated at 37°C for 2h before addition of lysis buffer (100l SDS (20%), dimethylformamide (50%), pH4.7 with acetic acid). Formazan release was read (570nm) after 16h at 37°C in a Dynex plate reader.
Protein assay:
Protein content was determined by the bichinchoninic acid assay [22] .
Glutathione assay:
Triplicate samples of SH-SY5Y cells (2x10 5 ) were harvested after exposure to oxidative stress and antioxidants for the varying times and doses described.
Glutathione levels were measured as described by Punchard et al. [23] . Briefly, cells
were washed in PBS and pelleted prior to protein precipitation and extraction with sulfosalicylic acid (3.3l, 100%w/v). After centrifugation, 125mM sodium phosphate with 6.3mM EDTA (96.6l, pH 7.5) was added. Extracts (25l) were aliquoted into 96-well plates. To each well NADPH (150l, 0.3mg/ml, dissolved in 125mM sodium phosphate with 6.3mM EDTA pH7.5) and 5,5"-dithio-bis(2-nitrobenzoicacid) 3-carboxy-4-nitrophenyl disulphid (DTNB) (50l, 6mM DTNB in 125mM sodium phosphate with 6.3mM EDTA pH7.5) solutions were added. Glutathione reductase (25l, 20U/ml, Sigma) was added to each well and absorbance change (410nm) was recorded every 5min in a Dynex plate reader. Glutathione standards were prepared (0-2.5nmol/well) and treated in the same manner. Data are expressed as nmol glutathione per mg protein in order to correct for any variability in cell number dictated by cell treatment.
Carbonyl ELISA:
Proteins (1g per well) from treated and control SH-SY5Y cells were bound to a Nunc immunosorb 96 well plate and carbonyl groups were derivatized with reduced dinotrophenylhydrazine (DNPH) prior to identification by a mouse monoclonal anti-DNP-antibody and secondary peroxidase coupled anti-mouse-antibody [24] . Data is expressed as nmol carbonyl per mg protein. This takes into account variability in cell number and protein loss through cell death.
Extraction of proteins:
SH-SY5Y cells (10x10 6 ) were harvested and then solubilized in rehydration buffer (urea (5M), thiourea (2M) CHAPS (2%), SB3-10 (2%), TBP (2mM), Tris HCl (40mM) and Biolytes 3/10 (0.5%)) by sonication (15min). The protein content of these preparations was determined by RCDC protein assay (BioRad).
Focussing of samples:
Immobilised pH gradient (IPG) strips (11cm, pH 3-10, BioRad) were used to separate proteins in the first dimension. Prepared proteins (50g) were applied during rehydration to the IPG strips in rehydration buffer (180l, 16h, 20°C). Proteins were focused on a Multiphor II with a DryStrip Kit and power was supplied by an EPS 3500XL power pack (Amersham Pharmacia Biotech), cooled to 20°C (Grant cooling system). The running conditions were: a gradient of 0V to 500V over 500Vh, 500V to 3500V for 3500Vh and finally 3500V for 90kVh. After focusing the IPG strips were stored at -70°C until required.
2DE:
Prior to the second dimension IPG strips were equilibrated in equilibration buffer (urea (6M), glycerol (20%), SDS (2%), tributyl phosphine (TBP;5mM), Tris (0.375M) pH 8.8) for 20min [25] . After equilibration IPG strips were placed above a 4-20% gradient gel (BioRad) and set in agarose (1%, in Tris/glycine/SDS (TGS) buffer (BioRad)). The proteins were electrophoresed in BioRad Critterion kit for 70min at 150V, using TGS buffer (BioRad). Gels were then either stained with silver [26] or immunoblotted as described. Silver stained gels were analysed with PDQuest software (BioRad). Changes in protein expression were identified using Boolean interrogation. Protein spots were thus identified as (1) those which were present throughout control, ascorbate and/or peroxide treatment (2) those that showed altered expression, and (3) those which were only present upon treatment. Changes in expression were subject to statistical analyses within the software, allowing fold changes in expression to be identified. Protein spots that showed a fold change of 5,
where the set included proteins spots whose quantity in treated cells was at least 5 times that of the corresponding spot in non-treated cells, were selected for further study.
Immunoblotting and detection of oxidized proteins:
Second dimension gels were transferred to a Hybond-P (PVDF) membrane Oxidized proteins were visualized with ECL plus (Amersham Pharmacia Biotech).
Films of each blot were analysed with PDQuest (BioRad) after scanning on a GS-710
Densitometer. After detection antibodies were removed with Restore buffer (Pierce) and proteins on the blot were detected with colloidal gold stain (Aurodye Forte, Amersham Pharmacia Biotech).
Identification of proteins:
For all protein identification by mass fingerprinting, 6 gels were run and relevant spots from all gels were pooled to gain sufficient quantities. Second dimension gels were silver stained [26] , proteins of interest were excised and tryptically digested as described by Gharahdagli et al. [27] . Peptides were extracted from the gel pieces as described by Hellman et al. [28] . Peptides were desalted with C18 ZipTips (Millipore) and mass fingerprints were produced at Alta Bioscience 
Immunoblotting
Cell extract (20g) was separated by SDS-PAGE on 12.5% polyacrylamide gels.
After transfer to PVDF membrane BDNF protein was selectively detected using a mouse monoclonal antibody directed against human BDNF (Abcam). A monoclonal antibody to mouse IgG conjugated to peroxidase (Sigma) and the ECL plus system (APBiotech) was used to visualize BDNF signals. To demonstrate equal protein loading blots were analysed with an antibody against -actin (Abcam).
Statistics
For biochemical assays, data are reported from three independent experiments. Data was evaluated statistically for multi-comparison using ANOVA with Dunnet"s post test, where p≤0.05 was considered significant. For 2DE, cell extracts from six independent experiments were analysed.
Results:
Incubation of SH-SY5Y cells with hydrogen peroxide decreased cell viability in a dose dependent manner. No significant decrease in viability was seen following treatment with 100M hydrogen peroxide (24h) but at 250µM a 69% reduction in viability that progressed to 92% after 500M hydrogen peroxide treatment was observed ( Figure 1 ). However, preincubation of SH-SY5Y cells with 100M ascorbate for 24h prior to co-incubation with peroxide (100 or 500µM) protected cell viability over the following 24h period. Ascorbate alone (50µM and 100µM) did not have any significant effect on SH-SY5Y cell viability ( Figure 1) . None of the peroxide treatments described had any significant effect on the oxidation of proteins as seen by carbonyl ELISA, despite a trend to increasing carbonyl with increasing peroxide. Neither did ascorbate alone exert any significant change in the amount of oxidized proteins at 48h (Figure 2) . Nevertheless, the presence of ascorbate (50 or 100µM) was seen to significantly inhibit carbonyl formation in peroxide (250 and 500µM) treated cells. Similarly, intracellular glutathione levels were not significantly altered at 48h by subjecting SH-SY5Y cells to the oxidative stress conditions described ( Figure 3 ). However, co-incubation with ascorbate (100µM) and peroxide (500µM) did significantly reduce GSH content. (Table 1) .
Intensity changes in the four spots are reported in Table 2 (Table 1) .
Protein, extracted from parallel gels that were silver stained, allowed for identification Grune et al. [29] showed that hydrogen peroxide induced protein degradation over control in C9 liver cells, which was inhibited by lactacystin, indicating a pathway through via the 20S proteasome. Davies [30] also demonstrated that hydrogen peroxide increased protein degradation in C9 cells, which could be prevented by immunoprecipitation of the 20S proteasome. Furthermore, Ernst et al [31] demonstrated that an increase in carbonyl content in OLN 93 cells is associated with an increase in proteolytic activity, when treated with hydrogen peroxide (100µM).
The fate of ascorbate and glutathione are linked within the cell. Recycling of dehydroascorbate by the loss of glutathione produces ascorbate once more that can "mop-up" reactive oxygen species within a cell. Uptake of ascorbate into the cell is via the GLUT receptor after the extracellular conversion of ascorbate to dehydroascorbate or by direct up-take of ascorbate via sodium dependent ascorbate transfer or glutamate-ascorbate heteroexchange [32] [33] [34] . However, the former is much more efficient. Indeed, Long and Halliwell [35] showed that the addition of ascorbate to cell culture medium could produce hydrogen peroxide. Herein, we detected a drop in 
